Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,039 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short-term and long-term outcomes of submucosal dissection for residual or recurrent colorectal tumors after endoscopic resection: Analysis of a multicenter prospective study.
Tanaka H, Uraoka T, Kobayashi N, Ohata K, Takeuchi Y, Chino A, Yamada M, Tsuji Y, Hotta K, Harada K, Ikematsu H, Murakami T, Tsuji S, Katagiri A, Hori S, Michida T, Suzuki T, Fukuzawa M, Kiriyama S, Fukase K, Murakami Y, Ishikawa H, Nagahara A, Saito Y. Tanaka H, et al. Dig Endosc. 2023 Dec 26. doi: 10.1111/den.14752. Online ahead of print. Dig Endosc. 2023. PMID: 38148178
[Ovarian clear cell adenofibromatous tumor: report of 2 cases].
Tsurunaga T, Iwai E, Okamoto Y, Ueda M, Yanagawa Y, Okamura S, Ueki M, Sugimoto O, Tanaka H, Yoshikawa T, et al. Tsurunaga T, et al. Among authors: tanaka h. Nihon Sanka Fujinka Gakkai Zasshi. 1992 Jan;44(1):105-8. Nihon Sanka Fujinka Gakkai Zasshi. 1992. PMID: 1541853 Japanese. No abstract available.
Corrigendum to "A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKI and platinum-based chemotherapy" [Lung Cancer 177 (2023) 44-50].
Takeda M, Shimokawa M, Nakamura A, Nosaki K, Watanabe Y, Kato T, Hayakawa D, Tanaka H, Takahashi T, Oki M, Tachihara M, Fujimoto D, Hayashi H, Yamaguchi K, Yamamoto S, Iwama E, Azuma K, Hasegawa K, Yamamoto N, Nakagawa K. Takeda M, et al. Among authors: tanaka h. Lung Cancer. 2024 Jun 17:107852. doi: 10.1016/j.lungcan.2024.107852. Online ahead of print. Lung Cancer. 2024. PMID: 38890056 No abstract available.
15,039 results
You have reached the last available page of results. Please see the User Guide for more information.